
The Hidden Cost of Diabetes Tech: Why 'Affordable Access' Is a Trojan Horse for Pharma Profit
The unified call for affordable diabetes technology masks a deeper regulatory battle. Who truly benefits from this 'access' push?

The unified call for affordable diabetes technology masks a deeper regulatory battle. Who truly benefits from this 'access' push?

The FDA's Digital Health Center of Excellence is here. But the real story behind this 'innovation' isn't patient care—it's regulatory capture. Explore the hidden costs.

Tennessee's massive new UTHSC medicine building isn't just about better healthcare; it’s a calculated play for regional medical dominance and tax dollars.

CVS Health is testing generative AI agents to 'improve care experiences.' But the unspoken truth is this is about labor cost reduction, not patient miracles.

VCU Health's move on Hospital-at-Home and RPM governance isn't about patient care; it's a power play defining the future of digital health.

The supposed 'best medical technology stocks' are a classic Wall Street trap. Discover the hidden losers in the 2024 MedTech boom.

Hospitals are ditching simple digital tools for 'agentic systems.' This isn't efficiency; it's a subtle power shift you need to understand.

Investigating the true winners in pediatric healthcare technology adoption, beyond the glossy press releases from Rady Children’s and CHOC.

The American Hospital Association's push for technology-enabled care isn't about patient convenience; it's about survival and market dominance. Digging into the **digital health** strategy.

Vizient's call for 2026 tech applications reveals the hidden battle for control over future healthcare technology investment.

Digital health tools promise patient empowerment, but the real story behind this 'revolution' in **healthcare technology** is far more complex and corporate.

The latest Health IT jobs report is a siren song. Digging into the data reveals a chilling shortage of true expertise, masking a systemic skills gap.